Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer

DOI: 10.1634/theoncologist.2015-0438

Keywords: Genes, BRCA1, Genes, BRCA2, Ovarian cancer, Poly(ADP-ribose) polymerase inhibitors, DNA damage, Biomarkers, cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text